Anticholinergic bronchodilators

Australian Prescriber

Volumn 26, Issue 2, 2003, Pages 33-35

  Seale, J Paul ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Ipratropium bromide; Tiotropium bromide

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; EDROPHONIUM; FENOTEROL; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR; QUATERNARY AMMONIUM DERIVATIVE; SALBUTAMOL; TIOTROPIUM BROMIDE;

ASTHMA; BITTER TASTE; BRONCHODILATATION; CHOLINERGIC NERVE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG HALF LIFE; DRUG INDICATION; DRUG STRUCTURE; HEADACHE; HEART OUTPUT; HEART PALPITATION; HUMAN; INHALATION; LONG TERM CARE; LUNG FUNCTION; LUNG INNERVATION; MENTAL HEALTH; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; NONHUMAN; PALLIATIVE THERAPY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SMOKING CESSATION; TACHYCARDIA; THROAT DISEASE; URINE RETENTION; VAGUS NERVE; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0037246126     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2003.026     Document Type: Review

References (3)

1. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002;19:209-16.
2. COMBIVENT Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. Chest 1994;105:1411-9.
3. Harrison BA, Pierce RJ. Comparison of wet and dry aerosol salbutamol. Aust N Z J Med 1983;13:29-33.